A comparative evaluation of hemostatic agents in the management of soft tissue graft donor site bleeding.
BACKGROUND
Periodontal plastic surgery has increased the use of palatal wounds for donor tissue, with the most common complication being excessive bleeding from the palate after harvesting tissue. This study was conducted to evaluate the efficacy of 3 methods for achieving hemostasis on the palate after harvesting donor tissue for autogenous soft tissue grafts.


METHODS
Thirty sites were evaluated at surgery for hemostasis and followed over 21 days for healing and adverse events. Three treatment groups were randomly selected and patients received either a test product or control comprising: 1) oxidized regenerated cellulose; 2) absorbable gelatin sponge; or 3) sterile gauze with external pressure as the control. All patients received a surgical stent for the palate.


RESULTS
The results were analyzed for smokers and non-smokers, and the median time to hemostasis was significantly shorter when a hemostatic agent was applied to the palatal wounds compared to controls in both groups. Pain assessment showed no differences across treatment groups. However, by 21 days, only the oxidized regenerated cellulose group had complete healing based on blinded clinical evaluation with all sites rated as normal to rapid healing, compared to the absorbable gelatin sponge group where 40% of the sites were rated as slow healing. Adverse events, primarily bleeding episodes during the first 7 days after surgery, were found in 40% of the oxidized regenerated cellulose and gauze control groups, while no sites in the absorbable gelatin sponge group had an adverse event. The patients were followed for an average of 10 months and demonstrated a mean shrinkage of their recipient grafts of 24% in total surface area.


CONCLUSIONS
This study concluded that the use of hemostatic agents for palatal wounds is confirmed as the treatment of choice when performing free soft tissue grafts.
Rossmann
J A
JA
Department of Periodontics, Baylor College of Dentistry, Dallas, TX 75266-0677, USA.
Rees
T D
TD
D000328:Adult; D002482:Cellulose / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D005780:Gelatin / Q000627:therapeutic use; D005881:Gingiva / Q000637:transplantation*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D006472:Oral Hemorrhage / Q000517:prevention & control; D010159:Palate / Q000601:surgery*; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012044:Regression Analysis; D012907:Smoking; D016019:Survival Analysis; D014182:Transplantation, Autologous / Q000009:adverse effects*; D014945:Wound Healing
D006490:Hemostatics; D005780:Gelatin; D002482:Cellulose